ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

GENE Genetic Technologies Ltd

2.39
-0.05 (-2.05%)
最終更新日: 04:17:42
15分遅延
名称 銘柄コード 市場 種別
Genetic Technologies Ltd GENE NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
-0.05 -2.05% 2.39 04:17:42
始値 安値 高値 終値 前日終値
2.43 2.27 2.43 2.44
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0621:00GLOBEGTG and ‘Wellworks for You’ sign B2B sales & marketing deal..
2024/4/2304:00GLOBEGenetic Technologies Announces Closing of US$2 Million..
2024/4/1901:17GLOBEGenetic Technologies Announces $2 Million Registered Direct..
2024/4/1721:00GLOBENew Precision Oncology Tests to Drive Personalised Therapies..
2024/4/1621:00GLOBEGeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year..
2024/4/1121:00GLOBEGTG to pilot GeneType in Breast Screen centers across the..
2024/4/0821:00GLOBEEVENT - Empowering Women Through Knowledge; Humanise Health..
2024/4/0221:05GLOBEGenetic Technologies’ Digital Strategy Ignites Significant..
2024/3/2621:00GLOBEGTG Global Collaborations and Innovation Update
2024/3/2521:00GLOBEGENE to develop Worlds Most Advanced Comprehensive Risk Test..
2024/2/2622:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1504:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3122:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/3122:00GLOBELaunching our most comprehensive test and expanding into new..
2024/1/0922:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0522:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0522:00GLOBEGenetic Technologies Regains Compliance with Nasdaq Minimum..
2024/1/0514:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/2822:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2722:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2107:00EDGAR2Form F-3 - Registration statement by foreign private issuers
2023/12/1422:00GLOBEGeneType's Groundbreaking Saliva Test Transforms Early..
2023/12/1222:00GLOBEGenetic Technologies Limited Announces Ordinary Share..
2023/10/3021:00GLOBEGene Business Update: Private Hospital Partnership; Expanded..
2023/10/1821:30GLOBEGeneType Predicting Risk of Pancreatic Cancer: Major..
2023/9/2722:00GLOBEGTG Signs Precision Medicine Pilot with Australia’s Largest..
2023/9/1221:00GLOBEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and..
2023/9/1121:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/1121:30GLOBEGENE Positioned at the Forefront of Multi-cancer Clinical..
2023/9/1121:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0123:00GLOBEGenetic Technologies Limited and 60 Degrees Pharmaceuticals..
2023/8/3021:45GLOBEAnnual Results – Momentum Building on our Commercial Plans
2023/8/0921:00GLOBEGenetic Technologies Limited Announces Updated Investor..
2023/7/2821:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2821:00GLOBEQuarterly Activities Update: Encouraging Growth for geneType..
2023/7/2121:00GLOBEGenetic Technologies Receives Nasdaq Notification Regarding..
2023/5/2321:00GLOBEGeneType featured on U.S. National TV to raise Breast Cancer..

最近閲覧した銘柄

Delayed Upgrade Clock